Results 81 to 90 of about 9,727 (175)

Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database. [PDF]

Biomedicines, 2022
Liu CH, Huang SC, Yin CH, Huang WC, Chen JS, Chen YS, Gan ST, Tzou SJ, Hsu CT, Wu HM, Wang WH.   +10 more
europepmc   +1 more source

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study. [PDF]

J Inflamm Res, 2023
Pang L, Xue X, He Y, Wang C, Han L, Li M, Qi H, Li C, Lu J.   +8 more
europepmc   +1 more source

Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial. [PDF]

Eur J Med Res, 2023
Yang DH, Chen HC, Wei JC.
europepmc   +1 more source

Treatment sequence patterns of urate-lowering therapy in Korean patients with gout: A common data model-based study. [PDF]

PLoS One
Kim MJ, Park EG, Kim C, Kang DY, Ryu B, Shin K.   +5 more
europepmc   +1 more source

Monitoring and Achievement of Target Serum Urate Among Gout Patients Receiving Long-Term Urate-Lowering Therapy in the American College of Rheumatology RISE Registry. [PDF]

Arthritis Care Res (Hoboken), 2023
Hammam N, Li J, Kay J, Izadi Z, Yazdany J, Schmajuk G.   +5 more
europepmc   +1 more source

Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia. [PDF]

Signal Transduct Target Ther
Nie S, Zhou S, Chen R, Li L, Sun Y, Liu J, Jin L, Shao X, Pang M, Su L, Luo F, Xu X, Hou FF.   +12 more
europepmc   +1 more source

Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. [PDF]

Ann Rheum Dis, 2023
Roddy E, Bajpai R, Forrester H, Partington RJ, Mallen CD, Clarson LE, Padmanabhan N, Whittle R, Muller S.   +8 more
europepmc   +1 more source

Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR) [PDF]

, 2013
Carlo Scirè, Carlomaurizio Montecucco, Fausto Salaffi, Giovanni Minisola, Greta Carrara, Leonardo Punzi, Marcello Govoni, Marco Cimmino, Marco Matucci-Cerinic, Maria Manara, Maria Monti, null null   +11 more
core   +1 more source

Perceptions About Asymptomatic Hyperuricemia and Views About Urate-Lowering Therapy in People With Asymptomatic Hyperuricemia. [PDF]

Arthritis Care Res (Hoboken)
Dalbeth N, Stewart S, Gamble GD, Mihov B, Stamp LK, Haslett J, Taylor WJ, Merriman TR, Tabi-Amponsah AD, Horne A, Neogi T, Pascart T, Andrés M, Peral-Garrido ML, Norkuviene E, Vazquez-Mellado J, Uhlig T, Sun M, Li C, Petrie KJ.   +19 more
europepmc   +1 more source

Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients. [PDF]

RMD Open, 2022
Te Kampe R, Boonen A, Jansen T, Janssen M, de Vries H, van Durme C.   +5 more
europepmc   +1 more source